41 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
of directors with respect to fiscal 2023 included:
drug safety, including the safety of clinical trial participants;
manufacturing and supply chain quality
8-K
EX-99.1
guztoxd1b
12 Dec 22
Regulation FD Disclosure
7:48am
424B3
8u54nyu3tu0pt
8 Aug 22
Prospectus supplement
5:47pm
S-4
a2nbndv
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
8-K
EX-99.1
f8i8t
7 Jun 22
Submission of Matters to a Vote of Security Holders
7:31am
8-K
EX-99.1
h6y57
10 Jan 22
Regulation FD Disclosure
7:06am
8-K
EX-99.1
qjffz5q
20 Sep 21
Regulation FD Disclosure
4:02pm